Supplemental Table 3 from Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC

Distribution of resistance ALK mutations by EML4-ALK variant subtype in (A) clinical and (B) liquid biopsy cohorts. P-value is derived from Fisher's test of v3 vs non-v3. Significance at the level of p